Marilyn Huang1, David A Iglesias2, Shannon N Westin2, Bryan Fellman3, Diana Urbauer3, Kathleen M Schmeler2, Michael Frumovitz2, Pedro T Ramirez2, Pamela T Soliman4. 1. Department of Obstetrics, Gynecology, and Reproductive Science, Magee-Women's Hospital of UPMC, Pittsburgh, PA 15213, USA. 2. Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, Houston, TX 77030, USA. 3. Department of Biostatistics, MD Anderson Cancer Center, Houston, TX 77030, USA. 4. Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: psoliman@mdanderson.org.
Abstract
OBJECTIVE: To evaluate whether preoperative age impacts surgical outcomes, complication rates, and/or recurrence in women undergoing pelvic exenteration. METHODS: All women who underwent a pelvic exenteration for any gynecologic indication at our institution from 1993 to 2010 were included. Women were stratified into groups based on age in years (young: ≤ 50, middle: 51-64, and senior: ≥ 65). Baseline characteristics, surgical outcomes, early (<60 days) and late (≥ 60 days) postoperative complications, and recurrence/survival outcomes were ascertained. Fisher's exact test or Kruskal-Wallis test was performed. Kaplan-Meier survival curves were compared. RESULTS: 161 patients were included (58 young, 62 in the middle, and 41 senior). Women in the young group predominately had a diagnosis of cervical cancer (82.8%) while women in the senior group primarily had a diagnosis of vulvar or vaginal cancer (70.7%). Senior women were also more likely to have hypertension (p < 0.0001) and pulmonary disease (p = 0.040). Operative time was significantly shorter for women in the senior group (8.5h) compared with the middle (9.5h) and young group (10.1h) (p = 0.0089). There were no significant differences in early or late complications when stratified by age. The overall survival did not differ between age groups (p = 0.3760). CONCLUSION: Although hypertension and pulmonary disease were more frequent in the senior age group, duration of surgery, blood loss, length of hospital stay and complication rates did not increase with age. Advanced chronological age should not be considered a contraindication to a potentially curative surgical procedure.
OBJECTIVE: To evaluate whether preoperative age impacts surgical outcomes, complication rates, and/or recurrence in women undergoing pelvic exenteration. METHODS: All women who underwent a pelvic exenteration for any gynecologic indication at our institution from 1993 to 2010 were included. Women were stratified into groups based on age in years (young: ≤ 50, middle: 51-64, and senior: ≥ 65). Baseline characteristics, surgical outcomes, early (<60 days) and late (≥ 60 days) postoperative complications, and recurrence/survival outcomes were ascertained. Fisher's exact test or Kruskal-Wallis test was performed. Kaplan-Meier survival curves were compared. RESULTS: 161 patients were included (58 young, 62 in the middle, and 41 senior). Women in the young group predominately had a diagnosis of cervical cancer (82.8%) while women in the senior group primarily had a diagnosis of vulvar or vaginal cancer (70.7%). Senior women were also more likely to have hypertension (p < 0.0001) and pulmonary disease (p = 0.040). Operative time was significantly shorter for women in the senior group (8.5h) compared with the middle (9.5h) and young group (10.1h) (p = 0.0089). There were no significant differences in early or late complications when stratified by age. The overall survival did not differ between age groups (p = 0.3760). CONCLUSION: Although hypertension and pulmonary disease were more frequent in the senior age group, duration of surgery, blood loss, length of hospital stay and complication rates did not increase with age. Advanced chronological age should not be considered a contraindication to a potentially curative surgical procedure.
Authors: M C Fleisch; P Pantke; M W Beckmann; H G Schnuerch; R Ackermann; M O Grimm; H G Bender; P Dall Journal: J Surg Oncol Date: 2007-05-01 Impact factor: 3.454
Authors: Christina Fotopoulou; Konstantinos Savvatis; Elisabeth Steinhagen-Thiessen; Marcus Bahra; Werner Lichtenegger; Jalid Sehouli Journal: Int J Gynecol Cancer Date: 2010-01 Impact factor: 3.437
Authors: Koji Matsuo; Shinya Matsuzaki; Rachel S Mandelbaum; Kazuhide Matsushima; Maximilian Klar; Brendan H Grubbs; Lynda D Roman; Jason D Wright Journal: J Surg Oncol Date: 2019-11-19 Impact factor: 3.454